The endocannabinoid system in guarding against fear, anxiety and stress

Nature Reviews. Neuroscience
B LutzCecilia J Hillard


The endocannabinoid (eCB) system has emerged as a central integrator linking the perception of external and internal stimuli to distinct neurophysiological and behavioural outcomes (such as fear reaction, anxiety and stress-coping), thus allowing an organism to adapt to its changing environment. eCB signalling seems to determine the value of fear-evoking stimuli and to tune appropriate behavioural responses, which are essential for the organism's long-term viability, homeostasis and stress resilience; and dysregulation of eCB signalling can lead to psychiatric disorders. An understanding of the underlying neural cell populations and cellular processes enables the development of therapeutic strategies to mitigate behavioural maladaptation.


Feb 1, 1971·Biochemical Pharmacology·A Chari-Bitron, T Bino
May 23, 1970·Nature·C T Tart
Jun 9, 2000·Annual Review of Neuroscience·J E LeDoux
Jun 13, 2002·Proceedings of the National Academy of Sciences of the United States of America·Jack C SipeBenjamin F Cravatt
Dec 4, 2002·Nature Medicine·Satish KathuriaDaniele Piomelli
Oct 4, 2003·Science·Giovanni MarsicanoBeat Lutz
Feb 21, 2004·Proceedings of the National Academy of Sciences of the United States of America·Anke WittingNephi Stella
Sep 17, 2004·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Lisa WalterNephi Stella
Nov 5, 2004·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Matthew N HillBoris B Gorzalka
Mar 25, 2005·The European Journal of Neuroscience·Sachin PatelCecilia J Hillard
Jun 28, 2005·The European Journal of Neuroscience·Gábor NyíriTamás F Freund
Dec 2, 2005·Annual Review of Psychology·Elizabeth A Phelps
May 26, 2006·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·István KatonaTamás F Freund
Jun 24, 2006·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Kornelia KamprathCarsten T Wotjak
Dec 13, 2006·Molecular Psychiatry·K M Myers, M Davis
Jan 26, 2007·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Rudolph MarschCarsten T Wotjak
Oct 24, 2007·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Pauline LafenêtreGiovanni Marsicano
Nov 22, 2007·Trends in Pharmacological Sciences·Ruth A Ross
Feb 1, 2008·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Rita NyilasIstván Katona
May 15, 2008·Cerebral Cortex·Hui-Ching LinPo-Wu Gean
Jun 17, 2008·British Journal of Pharmacology·H Meves
Jul 18, 2008·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Silvia RossiDiego Centonze
Aug 30, 2008·Neuropharmacology·Nephi Stella
Nov 11, 2008·Annals of the New York Academy of Sciences·A BruscoE S Onaivi
Dec 10, 2008·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Ana Luisa B TerzianFabrício A Moreira
Jan 23, 2009·Current Opinion in Pharmacology·Beat Lutz
Feb 21, 2009·Nature Reviews. Neuroscience·Karim Nader, Oliver Hardt
Mar 17, 2009·Best Practice & Research. Clinical Endocrinology & Metabolism·Fabrício A MoreiraBeat Lutz
Jul 18, 2009·Neuropharmacology·Pauline LafenêtreGiovanni Marsicano

❮ Previous
Next ❯


Apr 8, 2016·Nature Reviews. Neuroscience·H Valerie CurranLoren H Parsons
Aug 17, 2016·Proceedings of the National Academy of Sciences of the United States of America·Arnau Busquets-GarciaAndrés Ozaita
Sep 28, 2016·Translational Psychiatry·D S KarhsonK J Parker
Feb 22, 2017·Neuropharmacology·I MiedererR Urban
Apr 11, 2017·Progress in Neuro-psychopharmacology & Biological Psychiatry·Nicholas B WorleyJohn P Christianson
Dec 15, 2016·Pharmacology, Biochemistry, and Behavior·Tim RuhlGerhard von der Emde
Dec 22, 2016·Journal of Lipid Research·Vasudev KantaeThomas Hankemeier
Mar 24, 2017·Neuron·Pier Vincenzo PiazzaGiovanni Marsicano
Mar 28, 2017·European Archives of Psychiatry and Clinical Neuroscience·Laura KranasterAlexander Sartorius
Jul 8, 2017·Nutritional Neuroscience·Hércules Rezende FreitasRicardo Augusto De Melo Reis
Jun 20, 2017·Neuropharmacology·Alfonso AraqueRaffaella Tonini
Jul 12, 2016·Perspectives in Medicinal Chemistry·Eric W Bow, John M Rimoldi
Jul 27, 2017·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Matthew N HillSachin Patel
Jul 14, 2016·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Dan P CoveyJoseph F Cheer
Apr 10, 2018·Experimental & Molecular Medicine·Olga BabaevDilja Krueger-Burg
Feb 2, 2018·Journal of Traumatic Stress·Kevin M CrombieKelli F Koltyn
May 31, 2016·F1000Research·Arnau Busquets GarciaGiovanni Marsicano
Jun 22, 2019·The Journal of Comparative Neurology·Jana HedrichHeiko J Luhmann
Feb 16, 2019·Current Molecular Pharmacology·Lingyan YeNaiming Zhou
Jun 25, 2016·The Journal of Comparative Neurology·Ana Gutiérrez-RodríguezPedro Grandes
Oct 19, 2016·Molecular Pharmacology·Carlos Nogueras-Ortiz, Guillermo A Yudowski
Oct 1, 2019·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Sara PeñascoPedro Grandes
Oct 2, 2019·Journal of Dual Diagnosis·Hye Bin YooFrancesca M Filbey
Jan 11, 2020·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Jérémie NeastaSami Ben Hamida
Mar 13, 2020·Cerebral Cortex·Natália MadeiraRosalina Fonseca
Nov 13, 2019·Current Opinion in Psychiatry·Verity L ChadwickF Markus Leweke
Nov 7, 2019·Molecular Psychiatry·Peter ManzaNora D Volkow

❮ Previous
Next ❯

Related Concepts

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.


Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.


Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Frontiers in Behavioral Neuroscience
Michael V BarattaSteven F Maier
Fukuoka igaku zasshi = Hukuoka acta medica
Itta NakamuraSigenobu Kanba
© 2021 Meta ULC. All rights reserved